Infliximab Response in Inflammatory Bowel Disease
Rochester, MN
The specific objectives of this study are to define infliximab thresholds during induction therapy and during maintenance therapy (visit 6) that are associated with good prognosis/response, study the correlation of inflammation markers such as serum CRP and fecal calprotectin with infliximab and antibodies-to-infliximab, and evaluate how soon after initiation of therapy there is development of antibodies-to-infliximab